A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection

doi:10.1084/jem.183.3.1031

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Rodriguez, I.
	Articles by Vassalli, P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Rodriguez, I.
	Articles by Vassalli, P.


Social Bookmarking

	What's this?

ARTICLES

A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection

I Rodriguez, K Matsuura, K Khatib, JC Reed, S Nagata and P Vassalli
Department of Pathology, Centre Medical Universitaire, Geneva, Switzerland.

Stimulation of the Fas (APO-1, CD95) receptor, which is present on a variety of cells, usually triggers a process of programmed cell death. Systemic injection of anti-Fas antibody into mice leads to fulminant liver destruction resulting from massive hepatocyte apoptosis, and to rapid death. Hepatocytes bear Fas but do not express Bcl-2, a protein that plays, in a number of conditions, a protective role against apoptosis. We have generated mice whose liver expresses Bcl-2 as the result of bcl-2 transgene placed under the control of the hepatocyte- specific alpha1-anti-trypsin gene promoter, but is otherwise not distinguishable from that of normal mice. These mice display a marked to almost total resistance to liver damage induced by anti-Fas antibody injection. This protective effect of Bcl-2 occurs in the absence of significant variations, in the stimulated livers, in the level of expression of other proteins also involved in resistance or sensitivity to apoptosis, namely Bcl-x, Bax, Bad, Bak, and p53. Mice with protected livers, however, die almost as rapidly as normal mice, which indicates that acute lethality results from stimulation of Fas receptors present on other target organs or cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

McKenzie, M. D., Carrington, E. M., Kaufmann, T., Strasser, A., Huang, D. C.S., Kay, T. W.H., Allison, J., Thomas, H. E. (2008). Proapoptotic BH3-Only Protein Bid Is Essential For Death Receptor-Induced Apoptosis of Pancreatic {beta}-Cells. Diabetes 57: 1284-1292 [Abstract] [Full Text]
Nussbaum, A. K., Whitton, J. L. (2004). The Contraction Phase of Virus-Specific CD8+ T Cells Is Unaffected by a Pan-Caspase Inhibitor. J. Immunol. 173: 6611-6618 [Abstract] [Full Text]
Kreuz, S., Siegmund, D., Rumpf, J.-J., Samel, D., Leverkus, M., Janssen, O., Hacker, G., Dittrich-Breiholz, O., Kracht, M., Scheurich, P., Wajant, H. (2004). NF{kappa}B activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J. Cell Biol. 166: 369-380 [Abstract] [Full Text]
Jin, H., Carrio, R., Yu, A., Malek, T. R. (2004). Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis. J. Immunol. 173: 657-665 [Abstract] [Full Text]
Zhang, H., Taylor, J., Luther, D., Johnston, J., Murray, S., Wyatt, J. R., Watt, A. T., Koo, S., York-DeFalco, C., Stecker, K., Dean, N. M. (2003). Antisense Oligonucleotide Inhibition of Bcl-xL and Bid Expression in Liver Regulates Responses in a Mouse Model of Fas-Induced Fulminant Hepatitis. J. Pharmacol. Exp. Ther. 307: 24-33 [Abstract] [Full Text]
Jodo, S., Kung, J. T., Xiao, S., Chan, D. V., Kobayashi, S., Tateno, M., Lafyatis, R., Ju, S.-T. (2003). Anti-CD95-induced Lethality Requires Radioresistant Fcgamma RII+ Cells. A NOVEL MECHANISM FOR FULMINANT HEPATIC FAILURE. J. Biol. Chem. 278: 7553-7557 [Abstract] [Full Text]
Stegh, A. H., Barnhart, B. C., Volkland, J., Algeciras-Schimnich, A., Ke, N., Reed, J. C., Peter, M. E. (2002). Inactivation of Caspase-8 on Mitochondria of Bcl-xL-expressing MCF7-Fas Cells. ROLE FOR THE BIFUNCTIONAL APOPTOSIS REGULATOR PROTEIN. J. Biol. Chem. 277: 4351-4360 [Abstract] [Full Text]
Algeciras-Schimnich, A., Shen, L., Barnhart, B. C., Murmann, A. E., Burkhardt, J. K., Peter, M. E. (2002). Molecular Ordering of the Initial Signaling Events of CD95. Mol. Cell. Biol. 22: 207-220 [Abstract] [Full Text]
Trobonjaca, Z., Leithauser, F., Moller, P., Schirmbeck, R., Reimann, J. (2001). Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-{gamma} Release by Liver NKT Cells. J. Immunol. 167: 1413-1422 [Abstract] [Full Text]
OBERHOLZER, C., OBERHOLZER, A., CLARE-SALZLER, M., MOLDAWER, L. L. (2001). Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15: 879-892 [Abstract] [Full Text]
Vail, M. E., Pierce, R. H., Fausto, N. (2001). Bcl-2 Delays and Alters Hepatic Carcinogenesis Induced by Transforming Growth Factor {{alpha}}. Cancer Res. 61: 594-601 [Abstract] [Full Text]
Bajt, M. L., Lawson, J. A., Vonderfecht, S. L., Gujral, J. S., Jaeschke, H. (2000). Protection against Fas Receptor-Mediated Apoptosis in Hepatocytes and Nonparenchymal Cells by a Caspase-8 Inhibitor in Vivo: Evidence for a Postmitochondrial Processing of Caspase-8. Toxicol Sci 58: 109-117 [Abstract] [Full Text]
Roy, S., Nicholson, D. W. (2000). Cross-Talk in Cell Death Signaling. J. Exp. Med. 192: F21-F26 [Full Text]
Villunger, A., O'Reilly, L. A., Holler, N., Adams, J., Strasser, A. (2000). Fas Ligand, Bcl-2, Granulocyte Colony-Stimulating Factor, and p38 Mitogen-activated Protein Kinase: Regulators of Distinct Cell Death and Survival Pathways in Granulocytes. J. Exp. Med. 192: 647-658 [Abstract] [Full Text]
Gewies, A., Rokhlin, O. W., Cohen, M. B. (2000). Cytochrome c Is Involved in Fas-mediated Apoptosis of Prostatic Carcinoma Cell Lines. Cancer Res. 60: 2163-2168 [Abstract] [Full Text]
Lin, T., Genestier, L., Pinkoski, M. J., Castro, A., Nicholas, S., Mogil, R., Paris, F., Fuks, Z., Schuchman, E. H., Kolesnick, R. N., Green, D. R. (2000). Role of Acidic Sphingomyelinase in Fas/CD95-mediated Cell Death. J. Biol. Chem. 275: 8657-8663 [Abstract] [Full Text]
Zhang, H., Xu, Q., Krajewski, S., Krajewska, M., Xie, Z., Fuess, S., Kitada, S., Godzik, A., Reed, J. C. (2000). BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc. Natl. Acad. Sci. USA 97: 2597-2602 [Abstract] [Full Text]
Mandik-Nayak, L., Nayak, S., Sokol, C., Eaton-Bassiri, A., Madaio, M. P., Caton, A. J., Erikson, J. (2000). The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immunol 12: 353-364 [Abstract] [Full Text]
Walsh, K., Isner, J. M. (2000). Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall. Cardiovasc Res 45: 756-765 [Abstract] [Full Text]
Allison, J., Thomas, H., Beck, D., Brady, J. L., Lew, A. M., Elefanty, A., Kosaka, H., Kay, T. W., Huang, D. C. S., Strasser, A. (2000). Transgenic overexpression of human Bcl-2 in islet {beta} cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol 12: 9-17 [Abstract] [Full Text]
Huang, D. C. S., Hahne, M., Schroeter, M., Frei, K., Fontana, A., Villunger, A., Newton, K., Tschopp, J., Strasser, A. (1999). Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL. Proc. Natl. Acad. Sci. USA 96: 14871-14876 [Abstract] [Full Text]
Van Molle, W., Denecker, G., Rodriguez, I., Brouckaert, P., Vandenabeele, P., Libert, C. (1999). Activation of Caspases in Lethal Experimental Hepatitis and Prevention by Acute Phase Proteins. J. Immunol. 163: 5235-5241 [Abstract] [Full Text]
Woo, M., Hakem, A., Elia, A. J., Hakem, R., Duncan, G. S., Patterson, B. J., Mak, T. W. (1999). In Vivo Evidence That Caspase-3 Is Required for Fas-Mediated Apoptosis of Hepatocytes. J. Immunol. 163: 4909-4916 [Abstract] [Full Text]
de la Coste, A., Fabre, M., McDonell, N., Porteu, A., Gilgenkrantz, H., Perret, C., Kahn, A., Mignon, A. (1999). Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 277: G702-G708 [Abstract] [Full Text]
Niewiesk, S., Ohnimus, H., Schnorr, J.-J., Götzelmann, M., Schneider-Schaulies, S., Jassoy, C., ter Meulen, V. (1999). Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes. J. Gen. Virol. 80: 2023-2029 [Abstract] [Full Text]
Kakinuma, C., Takagaki, K., Yatomi, T., Nakamura, N., Nagata, S., Uemura, A., Shibutani, Y. (1999). Acute Toxicity of an Anti-Fas Antibody in Mice. Toxicol Pathol 27: 412-420 [Abstract]
Latta, M., Kunstle, G., Leist, M., Wendel, A. (1999). Metabolic Depletion of ATP by Fructose Inversely Controls CD95- and Tumor Necrosis Factor Receptor 1-mediated Hepatic Apoptosis. J. Exp. Med. 191: 1975-1986 [Abstract] [Full Text]
Andre, C., Couton, D., Gaston, J., Erraji, L., Renia, L., Varlet, P., Briand, P., Guillet, J.-G. (1999). beta 2-Adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 276: G647-G654 [Abstract] [Full Text]
Gross, A., Yin, X.-M., Wang, K., Wei, M. C., Jockel, J., Milliman, C., Erdjument-Bromage, H., Tempst, P., Korsmeyer, S. J. (1999). Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death. J. Biol. Chem. 274: 1156-1163 [Abstract] [Full Text]
Lieber, A., He, C.-Y., Meuse, L., Himeda, C., Wilson, C., Kay, M. A. (1998). Inhibition of NF-kappa B Activation in Combination with Bcl-2 Expression Allows for Persistence of First-Generation Adenovirus Vectors in the Mouse Liver. J. Virol. 72: 9267-9277 [Abstract] [Full Text]
Kuwana, T., Smith, J. J., Muzio, M., Dixit, V., Newmeyer, D. D., Kornbluth, S. (1998). Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome c. J. Biol. Chem. 273: 16589-16594 [Abstract] [Full Text]
Ksontini, R., MacKay, S. L. D., Moldawer, L. L. (1998). Revisiting the Role of Tumor Necrosis Factor {alpha} and the Response to Surgical Injury and Inflammation. Arch Surg 133: 558-567 [Abstract] [Full Text]
Van Parijs, L., Biuckians, A., Abbas, A. K. (1998). Functional Roles of Fas and Bcl-2-Regulated Apoptosis of T Lymphocytes. J. Immunol. 160: 2065-2071 [Abstract] [Full Text]
Hetts, S. W. (1998). To Die or Not to Die: An Overview of Apoptosis and Its Role in Disease. JAMA 279: 300-307 [Abstract] [Full Text]
Schwartz, S. M. (1998). Cell Death and the Caspase Cascade. Circulation 97: 227-229 [Full Text]
Hueber, A., Zörnig, M., Lyon, D., Suda, T., Nagata, S., Evan, G. I. (1997). Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis. Science 278: 1305-1309 [Abstract] [Full Text]
Mannick, J. B., Miao, X. Q., Stamler, J. S. (1997). Nitric Oxide Inhibits Fas-induced Apoptosis. J. Biol. Chem. 272: 24125-24128 [Abstract] [Full Text]
MacLellan, W. R., Schneider, M. D. (1997). Death by Design : Programmed Cell Death in Cardiovascular Biology and Disease. Circ. Res. 81: 137-144 [Abstract] [Full Text]
Boise, L. H., Thompson, C. B. (1997). Bcl-xL can inhibit apoptosis in cells that have undergone Fas-induced protease�activation. Proc. Natl. Acad. Sci. USA 94: 3759-3764 [Abstract] [Full Text]
Paris, F., Grassme, H., Cremesti, A., Zager, J., Fong, Y., Haimovitz-Friedman, A., Fuks, Z., Gulbins, E., Kolesnick, R. (2001). Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes. J. Biol. Chem. 276: 8297-8305 [Abstract] [Full Text]